Abstract
BackgroundAdoptive cell therapy with TIL has demonstrated efficacy in patients with advanced solid tumors, both as monotherapy in melanoma,1 NSCLC,2 and cervical cancer,3 and in combination with anti–PD-1 therapy in...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
